Table 1.
Demographic and Epidemiologic Characteristics of Patients With COVID‐19 With and Without NAFLD
| Variables (n [%] or Median [IQR]) | All Patients (N = 280) | Non‐NAFLD (n = 194) | NAFLD (n = 86) | P Value |
|---|---|---|---|---|
| Age (years) | 43.0 (32.0‐56.0) | 42.5 (31.8‐57.3) | 43.5 (32.8‐53.3) | 0.924 |
| Age range | 0.747 | |||
| ≤50 years | 185 (66.1) | 127 (65.5) | 58 (67.4) | |
| >50 years | 95 (33.9) | 67 (34.5) | 28 (32.6) | |
| Sex | 0.181 | |||
| Male | 146 (52.1) | 96 (49.5) | 50 (58.1) | |
| Female | 134 (47.9) | 98 (50.5) | 36 (41.9) | |
| BMI (kg/m2) | 24.2 (21.9‐26.2) | 23.1 (21.0‐24.8) | 27.1 (25.3‐29.7) | <0.001 |
| BMI range | <0.001 | |||
| <28 kg/m2 | 242 (86.4) | 191 (98.5) | 51 (59.3) | |
| ≥28 kg/m2 | 38 (13.6) | 3 (1.5) | 35 (40.7) | |
| Onset signs and symptoms | ||||
| Fever | 187 (66.8) | 132 (68.0) | 55 (64.0) | 0.503 |
| Cough | 156 (55.7) | 109 (56.2) | 47 (54.7) | 0.812 |
| Fatigue | 58 (20.7) | 42 (21.6) | 16 (18.6) | 0.562 |
| Sore throat | 32 (11.4) | 22 (11.3) | 10 (11.6) | 0.944 |
| Muscle ache | 28 (10.0) | 21 (10.8) | 7 (8.1) | 0.49 |
| Shortness of breath | 23 (8.2) | 16 (8.2) | 7 (8.1) | 0.976 |
| Headache | 19 (6.8) | 16 (8.2) | 3 (3.5) | 0.144 |
| Comorbidities | ||||
| Any comorbidity | 71 (25.4) | 44 (22.7) | 27 (31.4) | 0.122 |
| Hypertension | 45 (16.1) | 27 (13.9) | 18 (20.9) | 0.118 |
| Diabetes | 21 (7.5) | 11 (5.7) | 10 (11.6) | 0.081 |
| Chronic lung diseases | 10 (3.6) | 8 (4.1) | 2 (2.3) | 0.454 |
| Malignant tumor | 4 (1.4) | 2 (1.0) | 2 (2.3) | 0.4 |
| Exposure history | ||||
| Contact with suspected or confirmed patients | 164 (58.6) | 114 (58.8) | 50 (58.1) | 0.922 |
| Contacted with people from Wuhan or non‐Wuhan areas of Hubei Province | 102 (36.4) | 77 (39.7) | 25 (29.1) | 0.088 |
| Visited Wuhan or non‐Wuhan areas of Hubei Province | 97 (34.6) | 67 (34.5) | 30 (34.9) | 0.955 |
| Time from symptom onset to admission (days) | 5.0 (2.0‐8.0) | 5.0 (3.0‐8.0) | 4.5 (2.0‐8.0) | 0.258 |